Elinzano H, Toms S, Robison J, Mohler A, et al. Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial. Am J Clin Oncol 2020 Dec 4. doi: 10.1097/COC.0000000000000780.
PMID: 33284237